ASX:ANR - Anatara Lifesciences Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Anatara Lifesciences Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add A$0.20 0.00 (0.00 %) (As of 12/13/2019 04:00 PM ET) Add Compare Today's RangeA$0.19Now: A$0.20▼A$0.2050-Day RangeA$0.18MA: A$0.21▼A$0.2452-Week RangeA$0.16Now: A$0.20▼A$0.60Volume12,500 shsAverage VolumeN/AMarket Capitalization$9.91 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Anatara Lifesciences Limited engages in the development of non-antibiotic oral solutions for gastro intestinal diseases in animals and humans in Australia. Its lead product includes Detach, a non-antibiotic treatment to aid in the control of diarrhoeal diseas. The company is also developing bromelain formulations for gastrointestinal health. Anatara Lifesciences Limited is based in Brisbane, Australia. Industry, Sector and Symbol Stock Exchange ASX Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolASX:ANR Previous Symbol CUSIPN/A CIKN/A Webhttp://www.anataralifesciences.com/ Phone61 7 3394 8202Debt Debt-to-Equity RatioN/A Current Ratio14.03 Quick Ratio13.93Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$663,405.00 Price / Sales14.94 Cash FlowA$0.10 per share Price / Cash Flow1.93 Book ValueA$0.12 per share Price / Book1.67Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares49,562,700Market Cap$9.91 million Next Earnings DateN/A OptionableNot Optionable Receive ANR News and Ratings via Email Sign-up to receive the latest news and ratings for ANR and its competitors with MarketBeat's FREE daily newsletter. Anatara Lifesciences (ASX:ANR) Frequently Asked Questions What is Anatara Lifesciences' stock symbol? Anatara Lifesciences trades on the ASX under the ticker symbol "ANR." Has Anatara Lifesciences been receiving favorable news coverage? News stories about ANR stock have been trending somewhat negative on Saturday, according to InfoTrie. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Anatara Lifesciences earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Anatara Lifesciences. Who are some of Anatara Lifesciences' key competitors? Some companies that are related to Anatara Lifesciences include ReNeuron Group (RENE), Actinium Pharmaceuticals (ATNM), Biotron (BIT), Ixico (IXI), Immunoprecise Antibodies (IPA), Rhinomed (RNO), Noxopharm (NOX), Nuformix (NFX), Prescient Therapeutics (PTX), Biocardia (BCDA), ImmuPharma (IMM), Acrux (ACR), Bio-Gene Technology (BGT), Pharmaust (PAA) and Memphasys (MEM). What other stocks do shareholders of Anatara Lifesciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Anatara Lifesciences investors own include Brompton Oil Split Cl A (OSP), Eagle Materials (EXP), BHP Group (BHP), Ameriprise Financial (AMP) and Woodside Petroleum (WPL). Who are Anatara Lifesciences' key executives? Anatara Lifesciences' management team includes the folowing people: Dr. Tracie Elizabeth Ramsdale, Interim CEO & Exec. Director (Age 56)Dr. Tracey Mynott, Co-Founder, Chief Scientific Officer and R&D DirectorDr. Michael L. West Ph.D., Chief Operating Officer (Age 55)Dr. Terence Jean Brown, Chief Devel. Officer (Age 56)Mr. Alan Dowling, Group Accountant What is Anatara Lifesciences' stock price today? One share of ANR stock can currently be purchased for approximately A$0.20. How big of a company is Anatara Lifesciences? Anatara Lifesciences has a market capitalization of $9.91 million and generates $663,405.00 in revenue each year. View Additional Information About Anatara Lifesciences. What is Anatara Lifesciences' official website? The official website for Anatara Lifesciences is http://www.anataralifesciences.com/. How can I contact Anatara Lifesciences? The company can be reached via phone at 61 7 3394 8202. MarketBeat Community Rating for Anatara Lifesciences (ASX ANR)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 8 (Vote Outperform)Underperform Votes: 9 (Vote Underperform)Total Votes: 17MarketBeat's community ratings are surveys of what our community members think about Anatara Lifesciences and other stocks. Vote "Outperform" if you believe ANR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ANR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/14/2019 by MarketBeat.com StaffFeatured Article: How to Use a Moving Average for Trading
